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A synthesis of [“Qcopolamine capable of clinical delivery of this agent in high specific activity is 
described. The precursor [“Clformaldehyde was produced by catalytic oxidation of [“C]CH,OH over 
metallic silver and was used to N-“C-methylate norscopolamine using aqueous neutral potassium 
phosphite as the reducing agent. The labeling reaction was complete after 5min at 7580°C and the 
[“Clscopolamine (99% radiochemical purity) was isolated by preparative HPLC. Total synthesis time is 
less than 45 min. Decay corrected radiochemical yields from [“C]C02 are presently 2@43%. 
Introduction norscopolamine with [“C]CH,O, using potassium 
High densities of muscarinic cholinergic receptors are phosphite as the reducing agent under neutral aque- 
present in areas of the brain and heart (Levine et al., ous conditions. A catalytic [“C]CH,O synthesis with 
1986; Hirschowitz et al., 1984). Various diseases and improved specific activity and reproducibility is also 
disorders in these organs are thought to involve described. 
changes in the number and distribution of muscarinic 
receptors. High resolution in uiuo human imaging 
using PET and appropriately radiolabeled muscarinic 
Materials and Methods 
ligands could be of value in the study and possibly (-)Norscopolamine. HCl (m.p. 22O”C, lit. m.p. 
early diagnosis of disease processes involving the 203-205°C; Werner and Schickfluss, 1969) was pre- 
muscarinic cholinergic system. pared from scopolamine.HBr hydrate (Sigma) by 
[“ClScopolamine was chosen as a candidate for neutral KMnO, oxidative demethylation (Schmidt et 
PET studies following favorable evaluations of al., 1965). Final norscopolamine purification by prep- 
[‘HIscopolamine as a ligand for central muscarinic arative HPLC was necessary to remove small traces 
receptors in rats (Frey et al., 1985a, b, c). Sco- of scopolamine which would otherwise lower the 
polamine is a very potent antimuscarinic drug with a specific activity of the final radiolabeled product. 
binding affinity in the low nanomolar range. At the KH,PO,, 1 M pH 6.5, was prepared by neutral- 
same time it is a clinically familiar drug with a long ization of phosphorous acid (Aldrich) with K,CO, 
history of use in humans. [“ClScopolamine of low under inert atmosphere and was stored refrigerated in 
specific activity (14 Ci/mmol) previously has been a multidose vial. Stock reaction solutions of nor- 
prepared and evaluated in rats (Vora et al., 1983). scopolamine base (10 mg/mL) in 1 M phosphite were 
For the human studies planned, a synthesis capable prepared in advance and were stable for at least 3 
of delivering a minimum of 20 mCi of months when stored frozen. 
[“Clscopolamine with a specific activity of greater Analytical HPLC was performed using a 
than 300Ci/mmol was required. The present work 4.6 x 250 mm 5 micron C-18 column with an isocratic 
describes a convenient synthesis of high specific solvent system of 40~01% CH,CN, 10% CH,OH 
[“Clscopolamine by reductive N-[“Clmethylation of and 50% pH 6.5 2.0 mM KH,PO,, at a flow of 
0.7mL/min. Eluent was monitored by U.V. detector 
220nm (ISCO V4) in series with a y flow detector 
* Author for correspondence. (Beckman Model 170). In the analytical HPLC sys- 
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[“C ] CH,O 
pH 6.5 KHPO; 
norscopolamine 
I lg. I [“C]Scopolamine synthesis. 
tern the elution time Ihr norscopolamine was 6.6 min: 
for scopolamine 9.7 min. Tropic acid eluted in the 
void volume, and aposcopolaminc at I2 min. Prepa- 
rative HPLC was performed on two 9.4 x IOOmm 
Whatman PAC 5 micron columns in series using 90% 
CH,CN, IO”;, isopropanol as the solvent at 
3 ml/nun. Ultraviolet detection of cluate was at 
214 nm followed by radiation detection with an 
ionization chamber. Typical elution times in the 
preparative HPLC system were: scopolamine, IO mitt: 
norscopolaminc. I3 min. Degradation products in- 
cluding tropic acid and aposcopolamine eluted be- 
tween 4 and 7 min. Thin layer chromatography was 
performed on glass backed silica plates (Merck F254) 
which had been stored under ambient humidity con- 
ditions. using IO: IO: I: I CH,C12:Et,0:EtOH:EtJN 
as the developing solvent: scopolamine R, 0.65: nor- 
scopolamine R, 0.40: aposcopolamine R, 0.8. TLC 
plate radioactivity was quantitated using a Berthold 
Linear TLC scanner. 
[“C]Formaldehydc ([“C]CH,O) 
In a modified version of the procedure of Berger cur 
trl. (1980). [“C]CH,O was produced in two steps by 
lithium aluminun hydride reduction of [“C]CO, to 
[“C]CH,OH followed by oxidation over Ag to 
[“C]CHZO. No-carrier-added [“C]CO, was produced 
by proton irradiation of a nitrogen gas target. The 
[“C]C02 was concentrated by trapping in a glass loop 
cooled in liquid nitrogen. The loop was then warmed 
and the [“C]CO, transferred by N: flow to a conical 
tipped glass reaction vessel containing 100 /(L of a 
0.1 M tetrahydrofuran solution of lithium aluminum 
hydride (Fluka). The tetrahydrofuran was evapo- 
rated to dryness by warming under a stream of 
nitrogen. Eighty five percent phosphoric acid 
( - 100 /i L) was added to hydrolyze the residue of 
metal [“Clmethoxides. The [“C]CH,OH was distilled 
from the reaction vessel and was carried in a nitrogen 
stream (44 mL/min) through a column of Porapak P 
(6 mm x 70 mm). which removed traces of tetrahy- 
drofuran, then through a column of silver needles 
(Aldrich) at 390-C which catalytically oxidized the 
[“C]CH,OH to gaseous [“C]CHZO. Catalyst columns 
were prepared by loading 2 g of Ag needles into 4 mm 
i.d. Pyrex tubes. They were activated prior to radio- 
synthesis by heating in a luminous flame (- 525 ‘C) 
while purging with a stream of oxygen which had 
been bubbled through 10% MeOH 90% H@ Re- 
sidual CH,OH and CHzO were removed from the 
column by heating at 100-200’ C under pure 0, purge 
and then under Nz purge at 390°C for IO min prc- 
ceding [“C]CH,OH oxidation. 
A calorimetric (Sawicki et ol.. 1961) assay was used 
to help optimize formaldehyde production and iden- 
tify sources of carrier carbon. Known amounts of 
CH,OH vapor (&IO0 nmol) diluted in nitrogen gas 
were injected into the N: carrier upstream of the 
heated catalyst column. Gaseous effluents from 
the Ag catalyst column were bubbled into tubes 
containing 2OOpL of 0.2% aqueous 3-methyl-2- 
benzothiazolone hydrazone.HCI (MBTH. Aldrich) 
for I min at flow rates of 2&75 mL/min. The tubes 
were then placed in a 100 C heating block for 3 min. 
After cooling to room temperature. 12.5 /(L of 
0.4% FeCI, was added to each tube. After 5 min. 
samples were diluted to I mL total volume with 
acetone and absorbances were measured at 670 nm in 
I cm cuvettes. The intense blue derivatives obeys 
Beer’s law down to 2 nmol/mL and is qualitatively 
detectable to the eye at a level of 3.5 nmol CHLO/mL. 
Standard calibration curves over the range of 
0-~3 pmol CHzO were constructed by adding known 
amounts of aqueous CHzO to the MBTH reagent and 
processing samples as usual. 
Preparation qf’ [“C]scopolamine 
Gaseous high specific activity [“C]CH,O in a 
44mL/min N: carrier was bubbled through 
IS&250 /JL of stock reaction solution of 
norscopolamineiphosphite at room temperature. Af- 
ter the accumulated activity reached a maximum as 
measured by a silicon diode detector (Computrol 
RAD40), the reactor was sealed and heated in a 
75-80 C oil bath for 5 min. The reaction mixture was 
then applied to a 3 cm x 4.6 mm C- I8 cartridge pre- 
column which retained the [“Clscopolamine while 
permitting aqueous salts and other H,O soluble ma- 
terial to pass through to waste. After rinsing the 
reactor and pre-column with distilled water the pre- 
column was switched in line with the pumping HPLC 
organic mobile phase and the preparative HPLC 
columns by means of an electrically activated 8-port 
rotary injection valve. Adsorbed organics were eluted 
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from the pre-column onto the semiprep-columns 
where separation of [“Clscopolamine (retention time 
10 min) from unlabeled norscopolamine (13 min) was 
achieved. The [“Clscopolamine fraction cut was 
evaporated to dryness and formulated in saline con- 
taining 10% ethanol. The final product was assayed 
by analytical HPLC and TLC. 
Results and Discussion 
In exploratory efforts to label scopolamine with 
carbon-l 1, [“C]CH,I was tried first as the precursor 
because it is generally recognized to be more easily 
produced and in higher specific activity than the 
alternative [“C]CH,O. However, we were unable to 
label scopolamine in satisfactory yield using 
[“C]CH,I in base because of rapid decomposition of 
the alkaloid. These results agreed with previous ob- 
servations of Vora et al. (1983). Three points in the 
scopolamine molecule, the epoxide, the ester linkage 
and the hydroxymethyl function are known to be 
attacked under basic conditions by the routes shown 
in Fig. 3 (King, 1919; Schmidt et al., 1965; Werner 
and Schmidt, 1967; Willstatter and Berner, 1923). 
The major degradation product observed in these 
experiments was aposcopolamine, an unsaturated 
derivative produced by dehydration of the hydroxy- 
methyl group. Silyl or acyl protection of the hydroxyl 
a. 
SCOPl 
U V 214nm 
I 
mine Norscopolamine 
function did not prevent occurrence of this side 
reaction. Consequently we turned attention to reduc- 
tive labeling with [“C]CH,O as the precursor. 
[“C]Formaldehyde synthesis 
For clinical production of [“Clscopolamine, we 
required a catalyst for the oxidation of [“Clmethanol 
to [“Clformaldehyde that was reliable and simple to 
prepare for repeated syntheses. A molybdate catalyst 
(Christman et al., 1972) was found to introduce 
unacceptable levels of carrier carbon. We thus devel- 
oped a modification of the procedure of Berger et al. 
(1979, 1980), which used a silver catalyst. Inexpensive 
silver needles rather than wire were used, allowing the 
catalyst to be simply poured into glass columns rather 
than packed. By use of the sensitive calorimetric 
formaldehyde assay of Sawicki et al., (1961). a re- 
liable method of catalyst activation was found which 
contributed less than 10nmol of carrier for- 
maldehyde to the synthesis and which gave a max- 
imum formaldehyde yield at about 390°C. The Ag 
columns were reusable after reactivation with no loss 
of catalytic efficiency. The yield was relatively 
unaffected by small variations in temperature which 
allowed the catalyst temperature to be controlled by 
a small insulated aluminum heating block instead of 
an oven. The use of water to decompose the metal 
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Fig. 2. Preparative (a) and analytical (b) HPLC chromatograms during typical [“Clscopolamine synthesis. 







Fig. 3. Decomposition routes of (nor)scopolamine in hase. 
LiAlH, adversely affected the [“C]formaldehyde yield 
both by interference with the catalytic oxidation 
(Madix, 1986) and also by causing condensation in 
the transfer lines which retained significant amounts 
of formaldehyde. This problem was avoided by using 
85% H,PO, to decompose the alkoxide. 
At the 33 nmol level the above method was found 
to convert nonradioactive methanol to formaldehyde 
reliably in 6&70% yield. Because of the large number 
of possible variables. e.g. flow rate, temperature. 
nature of carrier, catalyst bed volume and geometry, 
catalyst activation and oxygen content, detailed opti- 
mization of all parameters was not attempted. Never- 
theless, by the use of the Ag catalyst prepared as 
described above along with careful control of 
[“C]CH,OH synthesis to minimize the introduction 
of adventitious carbon and water, reliable yields of 
[“C]CH,O of specific activity 1500-3000 Ci/mmol at 
8-13 min EOB were achieved. The recent detailed 
studies by the oxidation of methanol on single silver 
crystals (Madix, 1986) indicate that further im- 
provement in yield may be obtainable by a more 
complete understanding and control of conditions. 
Phosphite reductive [“Clmethylation 
Reductive [“Clmethylation of amines with 
[“C]CH,O has most often been carried out using 
NaBH,CN as the reductant (Finn et al., 1984; Berger 
et al.. 1979; Boullais et al.. 1985). However, use of 
NaBH,CN in radiosyntheses of agents intended for 
humans is complicated by the fact that cyanide ion is 
released in the course of reaction and additional steps 
must be taken to assure the absence of cyanide from 
the final product. 
We sought to avoid this complication by in- 
vestigating other reducing agents. Phosphite came to 
our attention in a report (Loibncr rt ul., 1984) 
showing it to be useful in reductive methylations of 
simple primary and secondary amines. Preliminary 
non-radioactive experiments using formaldehyde as 
RR’NH + CHzO + H2P0, +RR’NCH, + H,PO, 
the limiting reagent showed that norscopolamine was 
readily converted to scopolamine. Additionally, it 
was found this reaction could be carried out in 
completely aqueous solution. An examination of the 
effect of temperature upon the rate of reductive 
methylation of norscopolamine with one equivalent 
of formaldehyde (Fig. 4) showed that the reaction at 
85°C was complete within 5min. Unlike methyl 
iodide methylation, reductive methylation using neu- 
tral phosphite was very clean with only minor 
amounts of scopolamine degradation products 
formed even at elevated (90 C) reaction tem- 
peratures. The purified product was chro- 
matographically and analytically identical to authen- 
tic scopolamine. 
The ability to conduct the methylation reaction in 
neutral aqueous solution offered practical advantages 
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Fig. 4. Effect of temperature on rate of phosphite mediated reductive methylation of norscopolamine. 
Initial conditions: 0.033 M norscopolamine. 0.033 M formaldehyde, 1 .O M pH 6.5 phosphite. Products 
were measured by reverse phase HPLC (see Methods section for conditions). 
from the standpoint of carbon-l I labeling. First, 
because gaseous [“Clformaldehyde is readily ab- 
sorbed into water (Boullais et al., 1985) even from 
very fast gas carrier streams, rapid and complete 
trapping of the [“Clformaldehyde in a small volume 
(IS&250 pL) of reaction solution was possible. This 
resulted in faster rates of N-[“Clmethylation because 
of the high effective concentrations of reactants. 
Second, no neutralization step was required after 
completion of the methylation reaction. Rapid iso- 
lation of labeled scopolamine could be achieved 
simply by passing the reaction solution through a 
C-l 8 sample enrichment cartridge which retained 
scopolamine and norscopolamine but allowed aque- 
ous inorganic salts to flush to waste. By configuring 
the C-l 8 cartridge with a rotary injection valve (Fig. 
5), the operations of sample extraction, concentration 
and HPLC injection for purification were combined 
in a single device. 
A diagram of the [“Cl methylation apparatus is 
shown in Fig. 5. Three two-position multiport rotary 
valves were linked together to control the operations 
of reagent addition and product workup with a 
minimum of switch throwing. Liquid transfers were 
effected either by syringe or with helium pressure. 
Utilization of standard electrically actuated HPLC 
type valves rendered assembly of the apparatus con- 
venient and resulted in a compact, reliable system 
which was amenable to automation. 
Preparative HPLC with a bonded aminocyano 
normal phase (Whatman PAC) was preferred over 
underivatized silica gel because the former packing 
was not adversely affected by the presence of water 
in the injection volume. Specific activity was deter- 
mined during preparative HPLC purification and was 
checked again by analytical HPLC. Scopolamine has 
a weak U.V. chromophore and its limit of detectibility 
under routine conditions in our analytical HPLC was 
20 ng (67 pmol). Specific activities and other data for 
the [“Clscopolamine synthesis are summarized in 
Table 1. 
Overall radioactivity balance for the [“C]scopolamine 
synthesis 
For a typical human dose preparation, approxi- 
mately 1100 mCi of [“C]C02 were accumulated from 
the target in a liquid nitrogen cooled loop at 4min 
past EOB (end-of-bombardment). By 33-38 min, be- 
tween 60 and 150 mCi of radiochemically pure 
[“C]scopolamine had been collected from the prepa- 
rative HPLC. This corresponds to decay corrected 
radiochemical yields between 20 and 43%. The bal- 
ance of radioactivity could be accounted for in the 
following three locations. The first portion, consti- 
tuting 7-20% of the total carbon-II, was in vent 
Table I. [“C]Scopolamine synthesis data 
Number of syntheses 19 
Synthesis time” 4G45 mill 
Decay corrected radiochemical 
yield rang? Z&43% 
Radiopurity > 99% 
Specific activity range’ 350-I 300 Ci/mmol 
Mean specific activity’ 650 Ci/mmol 
End of synthesis yield range’ 6&l 50 mCi 
“Including formulation for injection. 
bBased on [“CJCO, at EOB plus 4min. 
‘After HPLC purification. 
37x 
c !I formaldehyde 






Fig. 5. [“Cl-Methylation apparatus. Diagram shows rotary valve settings durmg passage of gaseous 
[“C]CH,O into aqueous phosphite reaction solution. After accumulated radioactivity has reached a 
maximum, reactor is sealed by switching valve la to position lb. and the heating bath is raised. The reactor 
is heated for 5 min then the reaction solution is transferred onto the C-18 cartridge by actuating valve 
2a to position 2b and applying helium pressure. The reactor and C-18 cartridge are rinsed with three I mL 
portions of HZ0 from the syringe. HPLC purification of the [“Clscopolamine now adsorbed to the C- I8 
cartridge is initiated by switching rotary valve 3a to position 3b. The HPLC column eluent is monitored 
by U.V. (214 nm) and radioactivity. The eluting [“Clscopolamine peak is collected by switching 3-way valve 
4 to the “collect” position. 
gases from the phosphite reduction reactor. This 
activity was dimedon (Berger et al., 1980) negative 
(no [“C]CH20 present), could be trapped on soda- 
lime and the trapped radioactivity for the most 
part was liberated when the sodalime is added to 
dilute H?SO,. On the basis of this behavior it is 
assumed that most of the reactor vent gas radio- 
activity was in the chemical form of CO,. 
The second portion (IO-30%) of radioactivity was 
found in the aqueous washings from the C-18 car- 
tridge precolumn. Analysis with the dimedon reagent 
showed little free [“C]CH,O. TLC analysis of the 
washings showed variable but significant amounts of 
activity remaining at the origin, and mobile. volatile 
activity, most of which was [“C]CH,OH as deter- 
mined by CC. No significant amount of 
[“C]scopolamine breakthrough from the C-18 car- 
tridge rinse was observed. The nature of the materi- 
al(s) at the TLC origin requires further investigatton 
and is uncertain at this time. It elutes near the void 
volume in the analytical RP-HPLC system. Possible 
identities are [“Clmethylated alkaloid fragments such 
as scopine or oscine (Schmidt et nl.. 1965; Willstatter 
and Berner, 1923) or [“Clhydroxymethylphosphonic 
acid HOCHPO,H which under certain conditions 
may be produced from phosphite and CHzO (Akad 
Wissenschaft DDR. 1985). 
The final balance of O&2% of the total decay 
corrected “C activity from a typical [“C]scopolamine 
synthesis appeared in the early fractions of the prep- 
arative HPLC, eluting several minutes before and 
cleanly separated from scopolamine. The retention 
behavior of this “C containing species is consistent 
with that of aposcopolamine. 
Summary and Conclusions Christman D., Crawford E., Friedkin M. and Wolf A. 
Improved production of [“C]CHrO on a routine 
(1972) Proc. Narl. Acad. Sci. USA 69, 988. 
Finn R. D., Boothe T. E., Vora M. M., Hildner J. C., Emran 
basis and its application for labeling clinical scale A. M. and Kothari P. J. (1984) Syntheses with isotopically 
doses of [“Clscopolamine in high specific activity has labelled carbon methyl iodide, formaldehyde and cyanide. 
been achieved. Further refinements in [“C]CH,O Int. J. Appl. Radial. Isot. 35, 323. 
production and speed of reductive methylation 
Frey K. A., Ehrenkaufer R. L. E., Beaucage S. and AgranolI 
should be achievable which can make this approach 
B. W. (1985a) Quantitative in uiuo receptor binding 1. 
Theory and application to the muscarinic cholinergic 
very competitive with existing [“C]CH31 labeling receptor. J. Neurosci. 5, 421. 
procedures in terms of overall radiochemical yield. Frey K. A., Hichwa R. D., Ehrenkaufer R. L. E. and 
The usefulness of the phosphite mediated reductive Agranoff B. W. (1985b) Tracer kinetic modeling of mus- 
labeling procedure was demonstrated successfully in 
carinic cholinergic receptor binding. Proc. Natl. Acad. 
Sci. USA 82, 6771. 
a situation where, because of the base sensitivity of Frey K. A., Ehrenkaufer R. L. E. and Agranoff B. W. 
the scopolamine molecule, normal labeling attempts (1985~) Autoradiographic imaging of muscarinic choli- 
using [“C]CH31 had failed. A number of additional nergic receptors. J. Neurosci. 5, 2407. 
technical advantages followed from being able to 
Hirschowitz B. I., Hammer R., Giachetti A., Keirns J. J. and 
conduct “C-labeling under essentially neutral, totally 
Levine R. R. (1984) Subtvnes of muscarinic receptors I. 
Proc. Int. Syip. Tiends % Pharmacological &it&es 5, 
aqueous reaction conditions, including simplicity of (SUPPI.). 
reaction workup and product purification, fast syn- King H. (1919) The resolution of hyoscine and its com- 
thesis turnaround time (< 1 h) and the ease of system ponents, tropic acid and oscine. J. Chem. Sot. 115, 476. 
automation. It is believed that the phosphite 
Levine R. R., Birdsall J. M., Giachetti A., Hammer R., 
“C-labeling approach can be of general utility for 
Iverson L. L., Jenden D. J. and North R. A. (1986) 
Subtypes of muscarinic receptors II. Proc. 2nd Int. Symp. 
synthesis of a wide variety of [“C-methyl]amines for Trends in Pharmacol. Sciences 7, (Suppl.). 
applications with PET. Loibner H., Pruckner A. and Stiitz A. (1984) Reduktive 
Methylierung primarer und sekundarer amine mit Hilfe 
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